<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Induced mild therapeutic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> (MTH) is an effective treatment to improve outcome after out-of-hospital resuscitation </plain></SENT>
<SENT sid="1" pm="."><plain>Adverse events are rare, but <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> and <z:mp ids='MP_0001914'>bleeding</z:mp> complications have been reported </plain></SENT>
<SENT sid="2" pm="."><plain>So far, only few data about <z:hpo ids='HP_0011675'>electrocardiographic changes</z:hpo> and associated events have been reported </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Between 6/2005 and 3/2011, 109 comatose survivors of out-of-hospital <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo> admitted to our institution underwent MTH </plain></SENT>
<SENT sid="4" pm="."><plain>In an observational single-center study, we analyzed preclinical course, <z:hpo ids='HP_0011675'>electrocardiographic changes</z:hpo>, <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>, laboratory parameters and complication rates before, during and after MTH </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: MTH led to a significant decrease of heart rate (85.0±23.3 min(-1) at admission; 59.1±20.5 min(-1) during, p&lt;0.01 and 63.1±19.2 after <z:hpo ids='HP_0002045'>hypothermia</z:hpo> p&lt;0.05) a significant prolongation of PR (0.17±0.04 s before, 0.18±0.05 s during, p&lt;0.05; and 0.17±0.04 s after <z:hpo ids='HP_0002045'>hypothermia</z:hpo>, p&lt;0.01) and QTc intervals (0.47±0.05 s before, 0.49±0.05 s during, p&lt;0.01; and 0.46±0.05 s after <z:hpo ids='HP_0002045'>hypothermia</z:hpo>, p&lt;0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>Two patients developed <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> during <z:hpo ids='HP_0002045'>hypothermia</z:hpo>, both had an <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>No significant MTH related changes in electrolytes or coagulation parameters were observed </plain></SENT>
<SENT sid="8" pm="."><plain>Major <z:mp ids='MP_0001914'>bleeding</z:mp> complications occurred in four cases (3.7%) with a trend towards more <z:mp ids='MP_0001914'>bleedings</z:mp> after use of preclinical thrombolysis (21.4% with to 6.4% without thrombolysis, p=0.057) </plain></SENT>
<SENT sid="9" pm="."><plain>We did not find increased risk for <z:mp ids='MP_0001914'>bleeding</z:mp> complications in patients with double platelet inhibition after PCI (14.3% compared to 9.5% without PCI, p=0.63) compared to those without PCI </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Under strict clinical and laboratory parameter control, induced mild therapeutic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> can be applied to most patients after out-of-hospital <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo> with no increased risk for <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> despite significant <z:hpo ids='HP_0011675'>electrocardiographic changes</z:hpo> </plain></SENT>
</text></document>